Access to emergency contraception after removal of age restrictions

Tracey A. Wilkinson, Porsche Clark, Sally Rafi, Aaron Carroll, Elizabeth Miller

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

BACKGROUND: Levonorgestrel emergency contraception (EC) is safe and effective for postcoital pregnancy prevention. Starting in 2013, the US Food and Drug Administration removed age restrictions, enabling EC to be sold over the counter to all consumers. We sought to compare the availability and access for female adolescents with the 2012 study, using the same study design. METHODS: Female mystery callers posing as 17-year-old adolescents in need of EC used standardized scripts to telephone 979 pharmacies in 5 US cities. Using 2015 estimated census data and the federal poverty level, we characterized income levels of pharmacy neighborhoods. RESULTS: Of 979 pharmacies, 827 (83%) indicated that EC was available. This proportion did not vary by pharmacy neighborhood income level, nor was significantly different from the 2012 study (P = .78). When examining access, 8.3% of the pharmacies reported it was impossible to obtain EC under any circumstances, which occurred more often in lowincome neighborhoods (10.3% vs 6.3%, adjusted odds ratio 1.5; 95% confidence interval 1.20-1.94). This was not significantly different from 2012 (P = .66). Correct information regarding over-the-counter access was conveyed only 51.6% of the time; accuracy did not differ by pharmacy's neighborhood income (47.9% vs 55.3%, adjusted odds ratio 0.89; 95% confidence interval 0.71-1.11) and was not significantly different from 2012 (P = .37). CONCLUSIONS: A majority of pharmacies have EC available; however, barriers to and disparities in access for adolescents persist and have not changed since the previous study despite regulatory changes that were designed to improve access to EC.

Original languageEnglish (US)
Article numbere20164262
JournalPediatrics
Volume140
Issue number1
DOIs
StatePublished - Jul 1 2017

Fingerprint

Postcoital Contraception
Pharmacies
Odds Ratio
Confidence Intervals
Levonorgestrel
Censuses
United States Food and Drug Administration
Poverty
Telephone
Pregnancy

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Access to emergency contraception after removal of age restrictions. / Wilkinson, Tracey A.; Clark, Porsche; Rafi, Sally; Carroll, Aaron; Miller, Elizabeth.

In: Pediatrics, Vol. 140, No. 1, e20164262, 01.07.2017.

Research output: Contribution to journalArticle

Wilkinson, TA, Clark, P, Rafi, S, Carroll, A & Miller, E 2017, 'Access to emergency contraception after removal of age restrictions', Pediatrics, vol. 140, no. 1, e20164262. https://doi.org/10.1542/peds.2016-4262
Wilkinson, Tracey A. ; Clark, Porsche ; Rafi, Sally ; Carroll, Aaron ; Miller, Elizabeth. / Access to emergency contraception after removal of age restrictions. In: Pediatrics. 2017 ; Vol. 140, No. 1.
@article{58bfb18493c34cffa16bd97af35bff21,
title = "Access to emergency contraception after removal of age restrictions",
abstract = "BACKGROUND: Levonorgestrel emergency contraception (EC) is safe and effective for postcoital pregnancy prevention. Starting in 2013, the US Food and Drug Administration removed age restrictions, enabling EC to be sold over the counter to all consumers. We sought to compare the availability and access for female adolescents with the 2012 study, using the same study design. METHODS: Female mystery callers posing as 17-year-old adolescents in need of EC used standardized scripts to telephone 979 pharmacies in 5 US cities. Using 2015 estimated census data and the federal poverty level, we characterized income levels of pharmacy neighborhoods. RESULTS: Of 979 pharmacies, 827 (83{\%}) indicated that EC was available. This proportion did not vary by pharmacy neighborhood income level, nor was significantly different from the 2012 study (P = .78). When examining access, 8.3{\%} of the pharmacies reported it was impossible to obtain EC under any circumstances, which occurred more often in lowincome neighborhoods (10.3{\%} vs 6.3{\%}, adjusted odds ratio 1.5; 95{\%} confidence interval 1.20-1.94). This was not significantly different from 2012 (P = .66). Correct information regarding over-the-counter access was conveyed only 51.6{\%} of the time; accuracy did not differ by pharmacy's neighborhood income (47.9{\%} vs 55.3{\%}, adjusted odds ratio 0.89; 95{\%} confidence interval 0.71-1.11) and was not significantly different from 2012 (P = .37). CONCLUSIONS: A majority of pharmacies have EC available; however, barriers to and disparities in access for adolescents persist and have not changed since the previous study despite regulatory changes that were designed to improve access to EC.",
author = "Wilkinson, {Tracey A.} and Porsche Clark and Sally Rafi and Aaron Carroll and Elizabeth Miller",
year = "2017",
month = "7",
day = "1",
doi = "10.1542/peds.2016-4262",
language = "English (US)",
volume = "140",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "1",

}

TY - JOUR

T1 - Access to emergency contraception after removal of age restrictions

AU - Wilkinson, Tracey A.

AU - Clark, Porsche

AU - Rafi, Sally

AU - Carroll, Aaron

AU - Miller, Elizabeth

PY - 2017/7/1

Y1 - 2017/7/1

N2 - BACKGROUND: Levonorgestrel emergency contraception (EC) is safe and effective for postcoital pregnancy prevention. Starting in 2013, the US Food and Drug Administration removed age restrictions, enabling EC to be sold over the counter to all consumers. We sought to compare the availability and access for female adolescents with the 2012 study, using the same study design. METHODS: Female mystery callers posing as 17-year-old adolescents in need of EC used standardized scripts to telephone 979 pharmacies in 5 US cities. Using 2015 estimated census data and the federal poverty level, we characterized income levels of pharmacy neighborhoods. RESULTS: Of 979 pharmacies, 827 (83%) indicated that EC was available. This proportion did not vary by pharmacy neighborhood income level, nor was significantly different from the 2012 study (P = .78). When examining access, 8.3% of the pharmacies reported it was impossible to obtain EC under any circumstances, which occurred more often in lowincome neighborhoods (10.3% vs 6.3%, adjusted odds ratio 1.5; 95% confidence interval 1.20-1.94). This was not significantly different from 2012 (P = .66). Correct information regarding over-the-counter access was conveyed only 51.6% of the time; accuracy did not differ by pharmacy's neighborhood income (47.9% vs 55.3%, adjusted odds ratio 0.89; 95% confidence interval 0.71-1.11) and was not significantly different from 2012 (P = .37). CONCLUSIONS: A majority of pharmacies have EC available; however, barriers to and disparities in access for adolescents persist and have not changed since the previous study despite regulatory changes that were designed to improve access to EC.

AB - BACKGROUND: Levonorgestrel emergency contraception (EC) is safe and effective for postcoital pregnancy prevention. Starting in 2013, the US Food and Drug Administration removed age restrictions, enabling EC to be sold over the counter to all consumers. We sought to compare the availability and access for female adolescents with the 2012 study, using the same study design. METHODS: Female mystery callers posing as 17-year-old adolescents in need of EC used standardized scripts to telephone 979 pharmacies in 5 US cities. Using 2015 estimated census data and the federal poverty level, we characterized income levels of pharmacy neighborhoods. RESULTS: Of 979 pharmacies, 827 (83%) indicated that EC was available. This proportion did not vary by pharmacy neighborhood income level, nor was significantly different from the 2012 study (P = .78). When examining access, 8.3% of the pharmacies reported it was impossible to obtain EC under any circumstances, which occurred more often in lowincome neighborhoods (10.3% vs 6.3%, adjusted odds ratio 1.5; 95% confidence interval 1.20-1.94). This was not significantly different from 2012 (P = .66). Correct information regarding over-the-counter access was conveyed only 51.6% of the time; accuracy did not differ by pharmacy's neighborhood income (47.9% vs 55.3%, adjusted odds ratio 0.89; 95% confidence interval 0.71-1.11) and was not significantly different from 2012 (P = .37). CONCLUSIONS: A majority of pharmacies have EC available; however, barriers to and disparities in access for adolescents persist and have not changed since the previous study despite regulatory changes that were designed to improve access to EC.

UR - http://www.scopus.com/inward/record.url?scp=85021753961&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021753961&partnerID=8YFLogxK

U2 - 10.1542/peds.2016-4262

DO - 10.1542/peds.2016-4262

M3 - Article

C2 - 28759402

AN - SCOPUS:85021753961

VL - 140

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 1

M1 - e20164262

ER -